- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04845464
Sleep Quality and Cognition in Young Adults
14. april 2021 opdateret af: mbudak, Istanbul Medipol University Hospital
The Relationship Between Sleep Quality and Cognition in Young Adults
Sleep quality is impaired in young adults due to current conditions.
Recent studies emphasize that this situation may also affect the cognitive status of individuals.
The aim of this study was to investigate the relationship between sleep quality and cognitive status in young adults.
A total of 122 young adults (61 female, 61 male) aged between 18 to 25 and studied at Istanbul Medipol University, Faculty of Health Sciences, were included in the study.
Individuals were evaluated with "Pittsburgh Sleep Quality Index (PSQI)" for sleep quality; with "Montreal Cognitive Status Scale (MoCA)" for cognitive status, with "STROOP Test" for selective attention; with "Verbal Fluency Test" for sustained attention; with "WMS-R digit Span Test" for auditory attention
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Observationel
Tilmelding (Faktiske)
122
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Istanbul, Kalkun, 34815
- Istanbul Medipol University
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 25 år (Voksen)
Tager imod sunde frivillige
Ja
Køn, der er berettiget til at studere
Alle
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
Healthy adults aged between 18 to 25
Beskrivelse
Inclusion Criteria:
- Signing the Informed Voluntary Consent Form
- Being in the age range of 18-25
Exclusion Criteria:
- having a sleep disorder
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Study Group
A group of young adults aged between 18 to 25
|
Sleep quality and cognition will be assessed in young adults
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Pittsburgh Sleep Quality Index
Tidsramme: 8 March - 26 April 2019
|
Pittsburgh Sleep Quality Index evaluates sleep quality and impairment in the last one month.
19 of the 24 PSQIquestions included were self-report questions.
The scale has 18 questions and 7 components: Subjective Sleep Quality "," Sleep Latency "," Sleep Duration ", "Sleep Efficiency", "Sleep Disturbance", "Sleep Medication" and Daytime Dysfunction".
The total score ranges from 0-21.
A total score greater than 5 indicates poor sleep quality.
|
8 March - 26 April 2019
|
|
Montreal Cognitive Assessment Test
Tidsramme: 8 March - 26 April 2019
|
Montreal Cognitive Assessment Test (MoCA) examines cognitive abilities such as visual / executive function, naming, episodic memory, attention, language, abstract thinking, and orientation.
The original cut-off score of the MoCA test is 26.
The cut-off score of 21 was adopted in Turkey.
MoCA takes about 10 minutes to apply, but shortened versions have been created to shorten the administration time
|
8 March - 26 April 2019
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
STROOP Test
Tidsramme: 8 March - 26 April 2019
|
The Stroop Test reflects selective attention, reading and color rendering processes.
It is a critical experimental task, often used in the study of automatic and parallel processing models with the speed of information processing.
Because of these features, the test is used not only in the evaluation of the cognitive processes of healthy individuals, but also in the evaluation of many psychiatric and neurological disorders
|
8 March - 26 April 2019
|
|
Verbal Fluency Test
Tidsramme: 8 March - 26 April 2019
|
Verbal Fluency Test evaluates the tasks performed with frontal and temporal lobe activation.
The purpose of this test is to evaluate the mental recall of words starting with the given letter or in the desired category within the prescribed time.
|
8 March - 26 April 2019
|
|
WMS-R digit Span Test
Tidsramme: 8 March - 26 April 2019
|
Digit Span Test is the eighth subtest in the Wechsler Memory Scale Developed Form, and evaluates the simple and complex attention of individuals.
This sub-test consists of two sub-sections, and a series of increasingly long numbers are read to the person.
Both subtests are related to auditory attention and short-term memory.
Two separate trials are made for each length sequence.
|
8 March - 26 April 2019
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
8. marts 2019
Primær færdiggørelse (Faktiske)
26. april 2019
Studieafslutning (Faktiske)
21. januar 2020
Datoer for studieregistrering
Først indsendt
10. april 2021
Først indsendt, der opfyldte QC-kriterier
10. april 2021
Først opslået (Faktiske)
15. april 2021
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
19. april 2021
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
14. april 2021
Sidst verificeret
1. april 2021
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- SleepCog2021
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .